The Venture Codex Logo

The Venture Codex

TOOPI Organics

3 aux Halies, Ecopole de la Reole, Loupiac-de-la-Reole, Aquitaine, 33190, France

Overview

Toopi Organics develops plant biostimulants derived from the fermentation of human urine. Its first commercial product, Lactopi Start, launched in France and Belgium and is approved for organic farming in five EU member states to aid early growth and phosphorus uptake. The company collected urine from almost 2 million EU citizens via waterless urinals at motorway rest areas, theme parks, and festival partnerships across several countries. Toopi plans to scale with a first full-scale industrial site in France in 2025, a second in Belgium, and two additional factories later in the EU. It will launch 120 agronomic trials across six target member states to test products on local crops and begin exports. Toopi closed a €16M Series A in September 2023 and has been awarded additional funding from the EIC Accelerator to ramp production and product development. Toopi Organics has developed a patented fermentation-based root biostimulant, Lactop Start, produced by stabilizing, hygienizing and fermenting collected human urine inoculated with bacteria to yield a concentrated microbial product. The biostimulant is used alongside mineral fertilizers and, according to the company, can cut synthetic fertilizer needs by up to 50% while maintaining yields and saving farmers 20–40% on fertilizing costs depending on input prices. Founded in 2019 and based in France, Toopi collects urine from motorway rest areas, theme parks, festivals and other public sites through partnerships such as VINCI Autoroutes, Futuroscope and WC Loc. The company holds regulatory approval from ANSES and is authorized to market its product in Belgium, Greece, Spain, Italy and Portugal. With the new €16M financing (an €11M Series A plus €5M in non-dilutive government funds), Toopi plans to expand its urine-collection network, launch three new urine-based products, hire a sales team and build two industrial sites in France and Belgium. By 2027 the startup aims to collect and convert more than 2 million liters of urine and have its biostimulants on 600,000 hectares of European crops.

Total raised
$26M
Funding rounds
4
Latest round
Equity
Latest activity
Nov 2023

Industries

  • Agriculture
  • Biotechnology
  • Chemical
Visit website

Recent funding

  1. Equity

    Nov 2023

    $6M

  2. Series A

    Sep 2023

    $12M

Team

  • Alexandra Carpentier

    CEO - Managing Director

    LinkedIn
  • Michael Roes

    Founding President

    LinkedIn
  • Rene Mesnage

    Director of Operations - COO

    LinkedIn
  • Pierre Huguier

    Chief Scientific Officer

    LinkedIn